Lung Cancer

lung cancer spread to liver :: Article Creator Tracking Lung Cancer's Path It's common for lung cancer to metastasize, or spread. In fact, 57 percent of lung cancer patients are diagnosed when the cancer has already metastasized, according to an editorial in the Annals of Cancer Epidemiology. [1] Lung cancer also has a preferred path, traveling most often to the bones, brain, adrenal glands, and liver. [2] [3] Why Does Lung Cancer Spread So Easily? Lung cancer may metastasize readily because the lungs are a cellular traffic hub of the body. "The job of the airway is to deliver oxygen to all of your cells, so it's easy for cancer cells to get from the airway lining to the blood and spread to other organs," says Paul Bunn, MD, a professor of medical oncology at the University of Colorado School of Medicine in Aurora. Why Do Lung Cancer Cells Spread to Certain Organs? "Some organs produce a cellular signal tha

stage 4 ampullary cancer survival rate :: Article Creator Ask Amy: I Feel Guilty Keeping My Stage 4 Cancer A Secret From Most Dear Amy: I'm a 57-year-old man. I was recently diagnosed with stage 4 prostate cancer. I am obviously not overjoyed, but I am totally accepting of this news. Living with – not dying of – cancer means a few lifestyle changes and the need to be more aware of things. My cancer is not curable, but it is treatable; similar to many other illnesses. I have a large circle of family, friends and acquaintances who have been supportive of me during my life. I have chosen to share my diagnosis with only a few of them. While I'm OK with my cancer, I know it isn't going to be well received by most people, and so that's why I've decided to keep it private. I hate seeing people I care about being in pain and/or distressed and knowing the knowledge of my illness will cause this in turn causes me much m

ssm pulmonologist :: Article Creator Division Of Pulmonary, Critical Care And Sleep Medicine Fiberoptic Bronchoscopy and Interventional Pulmonary Medicine A modern bronchoscopy suite with fluoroscopy is available for ambulatory and inpatient bronchoscopic procedures. Fellows have ample opportunities to develop skills in performing bronchoalveolar lavage, endobronchial and transbronchial lung biopsies in addition to endobronchial ultrasound (EBUS) and endoscopic ultrasound (EUS) directed procedures using both linear and radial instruments in diagnostic evaluation and staging in patients with suspected intrathoracic malignancy. Training in procedures such as PleurX catheter placement, talc pleurodesis, tracheal dilation, rigid bronchoscopy, thoracoscopy, endobronchial stenting, balloon bronchoplasty, argon photocoagulation (APC) and cryotherapy are performed when appropriate under the direction of board certified interventional pulmonology facul

lobular carcinoma in situ :: Article Creator What To Know About Different Types Of Breast Cancer Breast cancer can be categorized in several ways. Most often, it's classified by where it originates and whether it moves from that spot. According to the National Cancer Institute, about 1 in 8 U.S. Women develop breast cancer at some point. It's much less common in men, with only about 1 in 800 men likely to develop it during their lifetimes. Your breast comprises lobules and ducts surrounded by fatty and connective tissue. The glandular lobules produce milk that's transported to the nipple through the ducts. Breast cancer occurs when normal cells in the lobules, ducts, or other breast tissue become damaged and grow out of control. The abnormal cells rapidly grow and accumulate, forming a tumor mass. If a tumor grows but doesn't spread into nearby breast tissue, it's called a benign tumor and is not considered cancer.

one cell lung cancer :: Article Creator F.D.A. Approves Drug For Persistently Deadly Form Of Lung Cancer The Food and Drug Administration on Thursday approved an innovative new treatment for patients with a form of lung cancer. It is to be used only by patients who have exhausted all other options to treat small cell lung cancer, and have a life expectancy of four to five months. The drug tarlatamab, or Imdelltra, made by the company Amgen, tripled patients' life expectancy, giving them a median survival of 14 months after they took the drug. Forty percent of those who got the drug responded. After decades with no real advances in treatments for small cell lung cancer, tarlatamab offers the first real hope, said Dr. Anish Thomas, a lung cancer specialist at the federal National Cancer Institute who was not involved in the trial. "I feel it's a light after a long time," he added. Dr. Timothy Burns, a lung cancer specialist at the Univ